The modulation of members of the tumor necrosis factor receptor family (TNFR) including CD40, OX40, and 4-1BB is also currently a focus of investigation64,88–90, with amplification of CD27 signaling being explored for cancer immunotherapy67,91. This evidence concerns the gene CD27 and cancer.